BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11726199)

  • 1. LIGHT, a member of the TNF superfamily, induces morphological changes and delays proliferation in the human rhabdomyosarcoma cell line RD.
    Hikichi Y; Matsui H; Tsuji I; Nishi K; Yamada T; Shintani Y; Onda H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):670-7. PubMed ID: 11726199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
    Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW
    J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
    Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
    Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor.
    Ishida S; Yamane S; Ochi T; Nakano S; Mori T; Juji T; Fukui N; Itoh T; Suzuki R
    J Rheumatol; 2008 Jun; 35(6):960-8. PubMed ID: 18412315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
    Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling pathways of LIGHT induced macrophage migration and vascular smooth muscle cell proliferation.
    Wei CY; Chou YH; Ho FM; Hsieh SL; Lin WW
    J Cell Physiol; 2006 Dec; 209(3):735-43. PubMed ID: 16972254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production.
    Pasero C; Barbarat B; Just-Landi S; Bernard A; Aurran-Schleinitz T; Rey J; Eldering E; Truneh A; Costello RT; Olive D
    Eur J Immunol; 2009 Sep; 39(9):2502-14. PubMed ID: 19701890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of LIGHT/interferon-gamma-induced cell death in HT-29 cells.
    Chang YH; Chao Y; Hsieh SL; Lin WW
    J Cell Biochem; 2004 Dec; 93(6):1188-202. PubMed ID: 15486969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
    Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
    Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM.
    Heo SK; Ju SA; Lee SC; Park SM; Choe SY; Kwon B; Kwon BS; Kim BS
    J Leukoc Biol; 2006 Feb; 79(2):330-8. PubMed ID: 16275888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant, soluble LIGHT (HVEM ligand) induces increased IL-8 secretion and growth arrest in A375 melanoma cells.
    Hehlgans T; Männel DN
    J Interferon Cytokine Res; 2001 May; 21(5):333-8. PubMed ID: 11429164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes.
    Kanda N; Watanabe S
    Biochem Pharmacol; 2006 Aug; 72(4):463-73. PubMed ID: 16784723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIGHT regulates CD86 expression on dendritic cells through NF-kappaB, but not JNK/AP-1 signal transduction pathway.
    Zou GM; Hu WY
    J Cell Physiol; 2005 Dec; 205(3):437-43. PubMed ID: 15895390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1.
    Xu LG; Wu M; Hu J; Zhai Z; Shu HB
    J Leukoc Biol; 2002 Aug; 72(2):410-6. PubMed ID: 12149433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB.
    Wong CK; Tsang CM; Ip WK; Lam CW
    Allergy; 2006 Mar; 61(3):289-97. PubMed ID: 16436136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity.
    Keslacy S; Tliba O; Baidouri H; Amrani Y
    Mol Pharmacol; 2007 Feb; 71(2):609-18. PubMed ID: 17108260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
    Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
    Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.